Contacts and Location
Contact 1 | Zanda Daneberga |
---|---|
Contact 2 | Linda Gabrusenoka |
Enquire about this equipment | |
Organisational Unit |
Rīga Stradiņš University Institute of Oncology - Latvia, Rīga |
Description
Transgenomic WAVE® System; DHPLC (denaturing high-performance liquid chromatography); detection of known and unknown mutations and single nucleotide polymorphisms (SNPs).
Specification
DNASep® HT Cartridge - Patented column filled with non-porous matrix consisting of polystyrene-divinylbenzene (PS-DVB) copolymer microspheres. Injection capacity: 0.5 ng to 4 µg. Low Pressure Gradient Solvent Delivery System. Autosampler capability: 2 x 96 samples and 1 x 384 samples. Autosampler temperature: Factory present 14 °C ± 1 °C, adjustable: 4 °C to ambient. Sample volume: 200 µL max. on 96-well plate, higher on optional 48 well-plate. Injection volume: 1 - 450 µL; up to 2 mL with optional syringe.
Services
Transgenomic WAVE® Systems utilize DHPLC (denaturing high-performance liquid chromatography) in conjunction with the Transgenomic patented separation DNASep® Cartridges for mutation detection. WAVE Systems offer discovery and detection of genetic variation at close to 100% sensitivity— making it one of the most sensitive and accurate technologies for detection of known and unknown mutations and single nucleotide polymorphisms (SNPs).
Status
Funding Source
National Research Centers (VNPC) | - |
---|
Manufacturer
Transgenomic Inc. (manufacturer's website)
Model
WAVE system 4500HT
Availability
Information on availability on request
Access Level
Full Access
Calibrated
Yes, this equipment is calibrated.